Bortezomib was approved for medical use in the United States in 2003 and in Europe in 2004. Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.. Reference standards of Bortezomib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => 1-Bromo-2-methylpropane [catalogue_number] => PA 02 79510 [category_ids] => ,92,84, [chemical_name] => [weight] => 137.02 [form] => C4H9Br [cas] => 78-77-3 [pslug] => 78-77-3-1-bromo-2-methylpropane-pa0279510 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 02 79510
CAS :
Molecular Formula : C4H9Br
Molecular Weight : 137.02
stdClass Object ( [pname] => (1S)-(1S,2S,3R,5S)-Pinanediol-1-ammoniumtrifluoroacetate-3-methylbutane-1-boronate [catalogue_number] => PA 02 79520 [category_ids] => ,84, [chemical_name] => [weight] => 379.22 [form] => C17H29BF3NO4 [cas] => 477254-69-6 [pslug] => 477254-69-6-1s-1s-2s-3r-5s-pinanediol-1-ammoniumtrifluoroacetate-3-methylbutane-1-boronate-pa0279520 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 02 79520
Molecular Formula : C17H29BF3NO4
Molecular Weight : 379.22
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
